Evidence map›Paper›PMID 40661375›Full record

ArticlebioRxiv : the preprint server for biology2025

Two δ-Catenins, Plakophilin 4 and p120, Promote Formation of Distinct Types of Adherens Junctions.

Indrajyoti Indra, Regina B Troyanovsky, Farida V Korobova, Sergey M Troyanovsky

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Indrajyoti IndraDepartment of Dermatology, Northwestern University, The Feinberg School of Medicine, Chicago, IL 60611.
Regina B TroyanovskyDepartment of Dermatology, Northwestern University, The Feinberg School of Medicine, Chicago, IL 60611.
Farida V KorobovaCenter for Advanced Microscopy/Nikon Imaging Center, Northwestern University, Chicago, IL 60614.
Sergey M TroyanovskyDepartment of Dermatology, Northwestern University, The Feinberg School of Medicine, Chicago, IL 60611.ORCID 0000-0001-7368-9708

Funding

Cadherin Clusters and actin filamentsR01AR070166 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sergey M Troyanovsky · 2016 to 2026
$4.1M
Intercellular junctions and cell polarityR01GM148571 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sergey M Troyanovsky · 2023 to 2026
$1.8M
NIAMS NIH HHS R01 AR070166NIGMS NIH HHS R01 GM148571
6 · The paper itself

Abstract

Classic cadherins are instrumental for joining cells into tissues by producing cell-cell adhesions known as adherens junctions (AJs). These morphologically diverse structures are tailored to the specific cell sites, type of cells, and particular functions. The mechanism of AJ diversification remains unknown. Here we show that two members of the δ-catenin protein family, p120 and plakophilin 4 (pkp4), which interact with the juxtamembrane intracellular region of classic cadherins, promote distinct types of cadherin clustering thereby contributing to AJ specialization. The type controlled by p120 is driven by interactions between cadherin-associated protein, α-catenin, and actin filaments. This "canonical" clustering mechanism results in formation of AJs that play a major role in overall cell-cell adhesion. The type promoted by pkp4 is driven by an α-catenin-independent cadherin-F-actin interaction. It generates the so-called lateral spot AJs, which apparently function in processes other than cell-cell adhesion. Collectively, our study shows how δ-catenins regulate a balance between different types of AJs in epithelial cells.

Indexed as

adherens junctionsbinding to actincadherinp120-cateninplakophilin 4

Identifiers

PMID40661375
PMCPMC12259199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.